arrow
R

Roland E. Schmieder

universitätsklinikum erlangen
H指数:19
被引数:4,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of Semaglutide on Body Composition and GFR A Prespecified Analysis of the SMART Trial

司美格鲁肽对身体成分和GFR的影响:SMART试验的预先指定分析

2026-04-011
PRE
On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial

治疗期间收缩压与蛋白尿高血压患者肾功能保留的关系。VALUE试验

2025-12-311
PRE
Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive Patients

低达到的收缩压与糖尿病及非糖尿病高危高血压患者的肾脏保护相关

2025-07-012
OAAI
EFFECTS OF VALSARTAN VS AMLODIPINE ON THE INCIDENCE OF END-STAGE KIDNEY DISEASE IN HIGH-RISK HYPERTENSION: THE VALUE TRIAL

缬沙坦与氨氯地平对高风险高血压患者终末期肾病发生率的影响:VALUE试验

2025-05-010
PRE
EFFECTS OF THE GLP-1 RA SEMAGLUTIDE ON VASCULAR STRUCTURE AND FUNCTION IN PATIENTS WITH TYPE 2 DIABETES: RESULTS OF A PROSPECTIVE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

利拉鲁肽(GLP-1 RA)司美格鲁肽对2型糖尿病患者血管结构和功能的影响:一项前瞻性随机双盲安慰剂对照研究的结果

2025-05-010
PRE
LOW ACHIEVED SYSTOLIC BLOOD PRESSURE RELATED TO KIDNEY PROTECTION IN DIABETIC AND NON-DIABETIC HIGH-RISK HYPERTENSIVE PATIENTS

低收缩压与糖尿病及非糖尿病高危高血压患者的肾脏保护相关

2025-05-010
PRE